Potential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery

Yan Wang, Ying Xie, David Oupicky

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

This review discusses the potential of CXCR4 chemokine receptor in the design of anticancer and antimetastatic drug delivery systems. The role of CXCR4 in cancer progression and metastasis is discussed in the context of the development of several types of drug delivery strategies. Overview of drug delivery systems targeted to cancers that overexpress CXCR4 is provided, together with the main types of CXCR4-binding ligands used in targeting applications. Drug delivery applications that take advantage of CXCR4 inhibition to achieve enhanced anticancer and antimetastatic activity of combination treatments are also discussed.

Original languageEnglish (US)
JournalCurrent Pharmacology Reports
Volume2
Issue number1
DOIs
StatePublished - Feb 1 2016

Fingerprint

Chemokine CXCL12
Drug Delivery Systems
Drug delivery
CXCR4 Receptors
Chemokine Receptors
Pharmaceutical Preparations
Neoplasms
Neoplasm Metastasis
Ligands
Therapeutics

Keywords

  • CXCR4
  • Cancer
  • Drug delivery
  • Gene delivery
  • Metastasis
  • Nanoparticles
  • siRNA delivery

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Pharmacology
  • Drug Discovery

Cite this

Potential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery. / Wang, Yan; Xie, Ying; Oupicky, David.

In: Current Pharmacology Reports, Vol. 2, No. 1, 01.02.2016.

Research output: Contribution to journalReview article

@article{8a20a3efa53a4bf4a9f5391792761890,
title = "Potential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery",
abstract = "This review discusses the potential of CXCR4 chemokine receptor in the design of anticancer and antimetastatic drug delivery systems. The role of CXCR4 in cancer progression and metastasis is discussed in the context of the development of several types of drug delivery strategies. Overview of drug delivery systems targeted to cancers that overexpress CXCR4 is provided, together with the main types of CXCR4-binding ligands used in targeting applications. Drug delivery applications that take advantage of CXCR4 inhibition to achieve enhanced anticancer and antimetastatic activity of combination treatments are also discussed.",
keywords = "CXCR4, Cancer, Drug delivery, Gene delivery, Metastasis, Nanoparticles, siRNA delivery",
author = "Yan Wang and Ying Xie and David Oupicky",
year = "2016",
month = "2",
day = "1",
doi = "10.1007/s40495-015-0044-8",
language = "English (US)",
volume = "2",
journal = "Current Pharmacology Reports",
issn = "2198-641X",
publisher = "Springer International Publishing AG",
number = "1",

}

TY - JOUR

T1 - Potential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery

AU - Wang, Yan

AU - Xie, Ying

AU - Oupicky, David

PY - 2016/2/1

Y1 - 2016/2/1

N2 - This review discusses the potential of CXCR4 chemokine receptor in the design of anticancer and antimetastatic drug delivery systems. The role of CXCR4 in cancer progression and metastasis is discussed in the context of the development of several types of drug delivery strategies. Overview of drug delivery systems targeted to cancers that overexpress CXCR4 is provided, together with the main types of CXCR4-binding ligands used in targeting applications. Drug delivery applications that take advantage of CXCR4 inhibition to achieve enhanced anticancer and antimetastatic activity of combination treatments are also discussed.

AB - This review discusses the potential of CXCR4 chemokine receptor in the design of anticancer and antimetastatic drug delivery systems. The role of CXCR4 in cancer progression and metastasis is discussed in the context of the development of several types of drug delivery strategies. Overview of drug delivery systems targeted to cancers that overexpress CXCR4 is provided, together with the main types of CXCR4-binding ligands used in targeting applications. Drug delivery applications that take advantage of CXCR4 inhibition to achieve enhanced anticancer and antimetastatic activity of combination treatments are also discussed.

KW - CXCR4

KW - Cancer

KW - Drug delivery

KW - Gene delivery

KW - Metastasis

KW - Nanoparticles

KW - siRNA delivery

UR - http://www.scopus.com/inward/record.url?scp=84993941069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84993941069&partnerID=8YFLogxK

U2 - 10.1007/s40495-015-0044-8

DO - 10.1007/s40495-015-0044-8

M3 - Review article

C2 - 27088072

AN - SCOPUS:84993941069

VL - 2

JO - Current Pharmacology Reports

JF - Current Pharmacology Reports

SN - 2198-641X

IS - 1

ER -